PRIMARY PERITONEAL CARCINOMA

This early-stage study is testing the safety and initial effectiveness of an experimental treatment called 27T51, a type of CAR T-cell therapy, for women with recurrent or hard-to-treat ovarian, primary peritoneal, or fallopian tube cancers. The first part will find the safest do…

This study is testing whether removing specific lymph nodes near the liver and stomach is safe and effective for women with advanced or returning ovarian cancer. Researchers will follow 94 patients who have this specialized surgery to see if it helps control the cancer longer. Th…

This study is testing a new type of treatment called CAR-NK cell therapy for women with ovarian cancer that has come back or stopped responding to standard treatments. Doctors first check the patient's tumor for specific markers and then give them a personalized infusion of modif…

This study is for people with advanced ovarian cancer who have had successful surgery to remove all visible tumor. It aims to find out if receiving 3 cycles of standard chemotherapy, followed by a maintenance drug called niraparib, is as effective at preventing the cancer from co…

This study is testing a new drug called Rina-S in people whose solid tumor cancers have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for people with several types of advanced cancer, including ovarian,…

This large Phase 3 trial is testing whether adding a new drug called IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 participants will be randomly assigned to receive either the standard che…

This study is testing whether cancer patients prefer to receive their standard drug treatments at home instead of in a clinic. Researchers want to see if home-based care reduces the burden of travel and improves treatment satisfaction and quality of life for patients. A specializ…

This study is collecting medical information from 2000 patients with low-grade ovarian or peritoneal cancers to build a comprehensive database. Researchers will review medical records and store tissue samples to better understand these specific tumor types. The goal is to analyze…

This study is collecting tissue and blood samples from cancer patients over time to create a research resource called a biobank. Researchers will analyze these samples to understand how cancer changes during treatment and why some treatments stop working. The goal is to help scie…

This study is testing a new radioactive dye for PET/CT scans to see if it can better show cancer cells in people with solid tumors, including ovarian, breast, and other cancers. Researchers want to see if this new imaging method can help measure a specific protein activity inside…